This aspect should be explored more deeply in the future, analyzing whether the five lncRNAs (NEAT1, MALAT1, pp14571, c17orf82, and TEMEM105) found at elevated levels in cisplatin-resistant cells could potentially serve as a signature for detecting chemoresistance in breast cancer, and investigating the mechanisms of action for each of these lncRNAs. This evidence concerns the gene NEAT1 and breast cancer.